Dr. Malik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9609 Medical Centre Drive
Rockville, MD 20850Phone+1 202-744-1694
Education & Training
George Washington UniversityFellowship, Hematology and Medical Oncology, 1994 - 1996
MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 1992 - 1994
UPMC Medical EducationResidency, Internal Medicine, 1983 - 1986
Government Medical College of Jammu and KashmireClass of 1979
Certifications & Licensure
DC State Medical License 1996 - 2024
VA State Medical License 2001 - 2024
MD State Medical License 1996 - 2001
PA State Medical License 1985 - 1992
GA State Medical License 1984 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 15 citationsIntegration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO).Jacob Sands, Sumithra J. Mandrekar, David Kozono, Geoffrey R. Oxnard, Shauna L. Hillman
Immunotherapy. 2021-04-21 - 10 citationsPathologic Considerations and Standardization in Mesothelioma Clinical Trials.Ming-Sound Tsao, Michele Carbone, Françoise Galateau-Sallé, Andre L. Moreira, Andrew G. Nicholson
Journal of Thoracic Oncology. 2019-10-01 - 80 citationsALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non–Small Cell Lung CancerRamaswamy Govindan, Sumithra J. Mandrekar, David E. Gerber, Geoffrey R. Oxnard, Suzanne E. Dahlberg
Clinical Cancer Research. 2015-12-15
Press Mentions
Cetuximab with Radiation Found to Be Inferior to Standard Treatment in HPV-Positive Oropharyngeal CancerAugust 23rd, 2018
Study: Cetuximab, Radiation Inferior to Standard HPV Throat Cancer TreatmentAugust 14th, 2018
Women, Elderly, Minorities Poorly Represented in Lung Cancer Drug Trial Data Submitted to US FDAJuly 6th, 2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
